Bevacacizumab and myalgia Patient Reports September 09, 2010

Bevacacizumab Side Effects Report #5298658-0
Bevacacizumab side effect was reported by a Physician from UNITED STATES on Mar 28, 2007. Female patient, 43 years of age, was diagnosed with breast cancer  and was treated with Bevacacizumab. After drug was administered, patient experienced the following side effects: myalgia. Bevacacizumab dosage: 818 MG, INTRAVENOUS. During the same period patient was treated with TAXOL, DOXORUBICIN, CYCLOPHOSPHAMIDE, NEULASTA, MEDROL. Patient was hospitalized. Patient recovered.